. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Endogenous Agonist Mechanism of Action of Class B GPCRs, Key to Small Molecule Drug Development

Reference #:

2005-210

Inventors/Contributors

Laurence J. Miller, M.D., Maoqing Dong

Description

We have identified a novel molecular mechanism of action of Class B GPCRs, a family that includes important potential drug targets. This information can be used to screen small molecule drug compounds.

Patent Status

Pending

Contact

Manu Nair, Licensing Manager
nair.manu@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Intellectual Property
MN BioBusiness Center
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-0558
Fax: (507) 284-5410